Author:
Kammar Praveen,Garach Niharika,Bhatt Aditi,Anam Jay,Maniar Vashisth,Gore Adwaita,Mehta Sanket
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M (1990) 2013) Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC. Eur J Cancer Oxf Engl 49(15):3140–8
2. Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S (2013) The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 20(4):1093–1100
3. Sugarbaker PH, Chang D (2017) Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 43(7):1228–1235
4. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O et al (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237–6242
5. Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN et al (2006) Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 13(3):405–412